T he number of abdominal wall reconstruction procedures, including ventral hernia repair, has been growing annually in the United States over the past several years, with over 350,000 such operations performed in 2014.
nosocomial infections, readmissions, blood transfusion, wound healing problems, surgical-site infections, and abscess formation. 4, 5 Abdominal wall reconstruction can be particularly challenging in obese patients, independent of the size of the hernia/defect. 3 Recent studies suggest that obesity increases the rates of complications after abdominal wall reconstruction, and elevated body mass index is associated with rates of wound healing complications and hernia recurrence as high as 48.7 and 41.7 percent, respectively, after abdominal wall reconstruction. [6] [7] [8] Further complicating this issue, over 54 percent of Americans have a centralized abdominal distribution of subcutaneous fat, or "abdominal obesity." 3 Therefore, surgical technique modifications have been described and proposed to improve surgical field exposure and limit postoperative wound healing complications in obese patients undergoing abdominal wall reconstruction. 9, 10 However, to date, only a few studies have compared abdominal wall reconstruction outcomes in obese and nonobese patients, and the data available are confounded by significant heterogeneity within cohorts, particularly regarding the type of the study population, the abdominal hernia/defect size, and the short duration of follow-up. 7, [11] [12] [13] [14] Some studies have analyzed the degree of obesity as an independent risk factor in abdominal surgical outcomes. 9, 10 Although abdominal wall reconstruction outcomes are worse in patients with a body mass index greater than or equal to 30 kg/m 2 , the relationship between the degree of obesity and postoperative complications in these procedures has not yet been clearly defined. [6] [7] [8] Quantifying the risk factors among different obesity classes could help to optimize the outcomes and minimize both complication and recurrence rates associated with abdominal wall reconstruction. It could also help surgeons properly screen and counsel patients preoperatively about abdominal wall reconstruction procedures.
The aim of this study was to assess the impact of the degree of body mass index on abdominal wall reconstruction complications and hernia recurrence outcomes in an attempt to quantify the differences between patients with class I or class II/III obesity compared with nonobese patients. We hypothesized that obese patients experience higher wound healing complication rates but similar hernia recurrence rates after abdominal wall reconstruction compared with nonobese patients.
PATIENTS AND METHODS
We queried the institutional database for consecutive patients who had undergone midline complex abdominal wall reconstruction with underlay (i.e., preperitoneal or intraperitoneal) or sublay (i.e., retrorectus) acellular dermal matrix for an abdominal wall ventral hernia and/ or oncologic resection defect 15 at The University of Texas M. D. Anderson Cancer Center from March of 2005 through October of 2015. We followed the Strengthening the Reporting of Observational Studies in Epidemiology guidelines for observational cohort studies. 16 We conducted this clinical investigation in accordance with the ethical principles of the World Medical Association Declaration of Helsinki and the laws of the United States of America. The institutional review board approved this study, and individual informed consent was waived because the source data were deidentified.
For the purpose of the present study, patients were divided into three groups on the basis of preoperative body mass index: less than 30 kg/ m 2 (nonobese), 30 to 35 kg/m 2 (class I obesity), and greater than or equal to 35 kg/m 2 (class II/III obesity). The outcomes of these groups of patients were compared.
Patients with lateral defects not involving the midline, primary closure of their abdominal wall fascia without mesh, onlay mesh reconstructions, use of mesh other than acellular dermal matrix, defects reconstructed or bridged with tissue from free or local musculocutaneous or fasciocutaneous flaps or fascial grafts, or follow-up less than 6 months were excluded from the study. We excluded synthetic mesh abdominal wall reconstructions because the number of cases in our database was too small for a meaningful statistical comparison.
Patients had been followed up with physical examination and computed tomographic imaging (88.8 percent of cases had a postoperative, use of mesh computed tomographic scan at followup). The abdominal wall reconstruction follow-up was robust because our institution serves an oncologic population; both clinical and radiologic surveillance were accomplished according to each patient's tumor protocol, typically quarterly for the first year and then annually thereafter. Data were collected accurately both from a prospectively maintained departmental database and from the patients' electronic medical records.
Patient, treatment, and defect characteristics were analyzed, and surgical outcomes were compared directly among the different groups. A Plastic and Reconstructive Surgery • May 2017 medical comorbidity was defined as having one or more of the following conditions: coronary artery disease, diabetes mellitus, hypertension, pulmonary disease, or renal disease. Wounds were considered contaminated if they met the American College of Surgeons National Surgical Quality Improvement Program definition of contaminated or infected (class 3 to 4). 17 Patients who smoked tobacco within 1 month of surgery were considered to be active smokers.
Recurrent hernia was defined as a contour abnormality associated with a fascial defect detected by physical examination and/or computed tomographic scan; bulging was defined as a contour abnormality without a fascial defect. Hernia and bulge were considered mutually exclusive conditions and were diagnosed by physical examination and/or computed tomographic imaging. The surgical techniques in abdominal wall reconstruction have been described previously. 15, 18 Surgical-site occurrence was defined as any complication involving the abdominal wall. Wound dehiscence was defined as a skin breakdown with full-thickness skin separation extending over 2 cm with or without infection, whereas skin necrosis involved clearly demarcated necrotic skin edges over 1 cm in width. Fat necrosis was defined as a palpable firmness 1 cm or greater in diameter that persisted beyond 3 months postoperatively. Infection was defined as an infectious process (cellulitis/abscess) requiring treatment with intravenous or oral antibiotics with or without surgery. Hematoma and seroma were defined as subcutaneous collections of blood or serous fluid, respectively, requiring percutaneous or operative drainage.
The primary outcome measure was surgicalsite occurrence after abdominal wall reconstruction. Secondary outcome measures were hernia recurrence, abdominal wall bulge, time to recurrence at follow-up, overall complications, surgicalsite infections, and incidences of the following postoperative complications: bulging or laxity of the abdominal wall and specific wound healing complications (i.e., skin dehiscence, skin necrosis, fat necrosis, cellulitis, abscess, hematoma, and seroma).
Statistical Analysis
Continuous variables were reported as the mean ± SD. The Pearson chi-square test or Fisher's exact test was used to assess association between categorical variables as appropriate. A two-sample t test was used for pairwise comparisons of continuous variables among the three body mass index groups. The correlations between preoperative body mass index and other continuous variables were evaluated with the Pearson or Spearman correlation coefficient. The Youden index was used to determine the best cutoff value of the body mass index value for surgical-site occurrence and the relative risk was calculated.
Time to hernia recurrence was defined as the time interval from the reconstructive surgery date to the first hernia recurrence date or the last follow-up date if a hernia recurrence had not yet occurred by that date. Hernia recurrence-free probability was estimated using the Kaplan-Meier product limit method that accounted for censoring. The differences in time to hernia recurrence among the three groups were evaluated by using the log-rank test.
Logistic regression and Cox proportional hazard regression models were used to estimate the odds ratios and hazard ratios for risk factors associated with surgical-site occurrence and hernia recurrence. A stepwise model selection method was used to fit a multivariate regression model. Values of p < 0.05 were considered statistically significant. All tests were two-sided. All analyses were carried out using IBM SPSS Version 23 (IBM Corp., Armonk, N.Y.).
RESULTS

Patient Demographics and Reconstructions
We identified 511 consecutive patients who underwent abdominal wall reconstruction with underlay or sublay acellular dermal matrix during the period of the study, with a mean followup for the overall series of 31.4 ± 22.4 months. The mean body mass index was 31.4 ± 6.8 kg/ m 2 . Two hundred seventy-six of the patients (54.2 percent) were obese (body mass index ≥30 kg/ m 2 ). Patients' baseline characteristics and risk factors are outlined in Table 1 , showing that obese patients had significantly higher rates of diabetes and hypertension, higher American Society of Anesthesiologists status, larger abdominal hernia defect sizes, and higher rates of pulmonary disease. Mean follow-up was similar among the groups.
Operative time was significantly longer in patients with a body mass index greater than or equal to 30 mg/kg 2 than in nonobese patients, but there was no difference between obesity class I and class II/III (Table 2) . Likewise, our surgeons used a component separation technique more often in patients with obesity class II/III than in nonobese patients (77.9 percent versus 62.1 percent; p = 0.002). Bridged repairs, paniculectomies, and tissue flaps were used in similar proportions among the groups. No differences between the body mass index groups were detected in the type of bioprosthetic used, including non-cross-linked porcine acellular dermal matrix (Strattice; Acelity Corp., Bridgewater, N.J.), non-cross-linked bovine acellular dermal matrix (Surgimend; TEI Biosciences, Inc., Boston, Mass.), and human cadaveric acellular dermal matrix (AlloDerm; Acelity). Plastic and Reconstructive Surgery • May 2017
Body Mass Index Class and Patient Outcomes
We detected a significant positive correlation between the patients' body mass indexes and the incidence of surgical-site occurrence (r = 0.22, p < 0.001), operative time (r = 0.18, p < 0.001), and estimated blood loss (r = 0.05, p < 0.001). In contrast, we did not find any significant correlation between body mass index and hospital stay (r = 0.03, p = 0.564) or hernia recurrence (r = 0.04, p = 0.418).
Patients with a body mass index greater than or equal to 30 mg/kg 2 had a more than 2-fold higher surgical-site occurrence rate, and patients with a body mass index greater than or equal to 35 mg/kg 2 had a more than 3-fold higher surgical-site occurrence rate compared with nonobese patients [26.4 Table 3) . The percentages of patients with and without surgical-site occurrence in each body mass index category are shown in Figure 1 . Similar significant differences were observed in overall complications, with lower rates corresponding to lower body mass index. In particular, patients with both class I and II/III obesity had significantly higher skin dehiscence and fat necrosis rates compared with nonobese patients. Infection and seroma rates were significantly higher in class II/III obese patients than in nonobese patients. No significant differences were detected between obesity class I and class II/III patients in the rates of surgical-site occurrence or any complication. The best body mass index break point identified by the receiver operating characteristic curve with respect to surgical-site occurrence was 31.9 kg/m 2 . Mesh exposure occurred more often in obesity class I patients compared with nonobese ones, but we observed no other differences in mesh-related complications. All three groups had similar rates of reoperation, readmission, and intensive care unit admission.
At follow-up, there was no difference in the hernia recurrence rates among the three groups. Time to recurrence was, however, shorter in class II/III obese patients than in class I obese patients. Kaplan-Meier curves did not show a significant difference in freedom from hernia recurrence among the three groups (Fig. 2) . The percentage of patients with and without hernia recurrence in each body mass index category is shown in Figure 3 . Univariate analysis showed body mass index greater than or equal to 30 kg/m 2 , stoma presence, comorbidity, diabetes, hypertension, wound contamination grade 3 or 4, defect width greater than or equal to 15cm, and panniculectomy to be associated with surgical-site occurrence (Table 4) . These factors were then analyzed with multivariate logistic regression, which confirmed that both ; 95 percent CI, 1.6 to 3.9; p < 0.001) were significant independent predictors of surgical-site occurrence (Table 4) .
Multivariable Cox proportional hazard regression models identified bridged repair (adjusted hazard ratio, 7.4; 95 percent CI, 4.0 to 13.7; p < 0.001), human acellular dermal matrix (adjusted hazard ratio, 3.2; 95 percent CI, 1.5 to 7.1; p = 0.003), coronary artery disease (adjusted hazard ratio, 2.9; 95 percent CI, 1.4 to 5.7; p = 0.002), smoking (adjusted hazard ratio, 2.9; 95 percent CI, 1.2 to 6.5; p = 0.013), and wound dehiscence (adjusted hazard ratio, 2.5; 95 percent CI, 1.3 to 4.9; p = 0.006) to be factors significantly associated with the development of hernia recurrence (Table 4) . Component separation was demonstrated to be an independent protective factor, with an almost three-fold reduction against hernia recurrence (adjusted hazard ratio, 0.4; 95 percent CI, 0.2 to 0.7; p < 0.001).
DISCUSSION
Many surgeons view obesity as a contraindication to performing abdominal wall reconstruction, yet denying obese patients abdominal wall reconstruction excludes a significant portion of the patient population suffering from the consequences of an abdominal incisional hernia. Our data support our hypothesis that obesity is associated with higher rates of complications compared with rates in nonobese patients. Indeed, we identified a body mass index cutoff of 31.9 kg/m 2 , using a receiver operating characteristic curve, above which the rate of surgical-site occurrence was significantly higher. However, although the rate of overall complications was higher and the length of surgery was longer, the rate of hernia recurrence was not found to be higher with increasing degree of obesity. Thus, although obese patients do appear to experience higher rates of wound healing complications, they do not necessarily experience higher rates of reconstruction failure or hernia recurrence.
Our finding that the incidence of the wound healing complications, skin dehiscence, fat necrosis, infection, and seroma increased with increasing body mass index corroborates results from previous studies on this topic. Many recent studies have shown a significantly higher complication rate among patients with a higher body mass index. 8, 9, [18] [19] [20] [21] [22] [23] [24] However, these studies were limited by small patient study populations, 19, 20 short postoperative follow-up, 19 or data obtained from the National Surgical Quality Improvement Program registry, which includes follow-up data occurring only within 30 days of surgery. 8, [20] [21] [22] [23] [24] Our obesity class III (body mass index ≥40 kg/m 2 ) population was limited (n = 46 patients) and did not allow us to corroborate a previous study showing that complications are most likely to occur in patients with a body mass index over 40 kg/m 2 .
24 Our data showing higher rates of wound healing complications among obese patients are also supported by recent experimental and epidemiologic studies demonstrating that there is a high degree of association between metabolic regulation and the immune response. 25, 26 As is widely known, low-grade chronic inflammation is present in obesity, where white adipose tissue and adipose tissue-derived macrophages secrete several cytokines, so-called adipokines, including tumor necrosis factor-α, interleukin-1, and interleukin-6. 25 The signals related to metabolic surplus in obese patients are similar to those present in response to injury and tissue repair, such as that caused by major surgical procedures such as abdominal wall reconstruction. 26 However, morbidly obese patients experience inefficient energy use because this extreme metabolic excess leads to hypermetabolic inflammatory responses, oxidative stress, and immunosuppression. 25, 26 For all these reasons, these patients are potentially not fully prepared to deal with high physiologic stress and may experience more postoperative complications and other adverse events compared with nonobese patients.
An excess of subcutaneous fat, which is relatively poorly perfused with low oxygen tension, in obese patients might predispose them to impaired wound healing and its associated complications. 27 Furthermore, obese patients have higher incidences of diabetes, insulin resistance, and poor glycemic control, all of which are known to increase the risk of postoperative complications. Although, we did not observe significant differences in complications between class I and class II/III obesity, we did notice a trend toward a progressive increase in complications with greater obesity (Table 3) .
In contrast to most of the previous studies, 8, 28, 29 we did not find significant differences in hernia recurrence among the different obesity classes. It has been speculated that patients with higher body mass indexes have greater intraabdominal pressure, which might affect the fascial integrity after reconstruction and thus predispose the patients to recurrences, particularly patients with visceral obesity. 8 Our similar hernia recurrence rates among the different obesity classes may be explained by the surgical technique adopted by our surgeons. Component separation was included in the majority of cases, and it was more common among obese patients likely because the parallel increase in body mass index and hernia/ defect size (Table 1 ) made component separation necessary to obtain a fascial coaptation. [29] [30] [31] Mesh choice is another important issue in these procedures. The use of bioprosthetic mesh has been shown to be associated with a low incidence of mesh-related infection, adhesion, and enterocutaneous fistulae 32 ; lower rates, mesh exposure leading to explantation, and reconstruction failure [31] [32] [33] [34] [35] [36] ; and fewer infectious wound complications. 32, 33 Bioprosthetic mesh has similar hernia recurrence rates compared to synthetic mesh 34 but has a higher initial cost. [31] [32] [33] [34] [35] [36] In our study, we found that mesh exposure seemed to be greater in class II/III obese patients compared with the nonobese group; however, this difference did not persist with mesh infection or removal rates, and it probably reflects the higher Plastic and Reconstructive Surgery • May 2017 skin dehiscence rates detected among the obese patients. The fact that acellular dermal matrix was typically placed in an underlay position to facilitate mesh revascularization from the posterior sheath may explain why acellular dermal matrix exposure did not appear to lead to serious sequelae such as mesh explantation. This placement allows for conservative wound management such as negative-pressure wound therapy in the case of delayed wound healing, and avoids further procedures in the operating room such as new mesh implantation, therefore reducing morbidity. 37, 38 Preoperative optimization of obese patients undergoing abdominal wall reconstruction is important to mitigate the risk of complications. Glucose control, smoking cessation, and nutritional therapy have shown significant promise. A recent study demonstrated that medically supervised weight loss before abdominal wall reconstruction can significantly reduce postoperative complications among morbidly obese patients and can be considered a possible additional strategy to minimize surgical-site occurrence. 7 In contrast, nonsurgical weight loss before abdominal wall reconstruction can lead to a delay of the abdominal wall reconstruction procedure. 7, 39 Nonetheless, the effects of preoperative weight loss on abdominal wall reconstruction outcomes, particularly hernia recurrence, are still not clear, and further research on this topic is warranted. 39 In contrast, if abdominal wall reconstruction cannot be delayed or preoperative weight loss is not achievable, laparoscopic abdominal wall reconstruction might be considered, as it has been shown to be associated with lower rates of complications (8.8 percent) and hernia recurrences (3.8 percent). 40 Laparoscopic abdominal wall reconstruction seems also to be associated with fewer surgical-site infections and reoperations 8 and with shorter hospital stays. 9 Nevertheless, in morbidly obese patients, a staged or concomitant bariatric operation has been shown to be safe and feasible. 41, 42 Given the possible additional wound healing risk, panniculectomy can also be performed with drain placement to minimize seroma formation in selected patients. 7, 20, 43, 44 The strengths of this study include its large sample size, consistent surgical technique, long-term follow-up, and relatively large defect/hernia sizes. We considered a large number of variables to minimize confounders. Also, our center's routine tumor recurrence surveillance protocols with both clinical examination and computed tomographic scans (in 88.8 percent of cases) confer very high sensitivity and specificity for hernia recurrence detection that is unmatched in the medical literature. 45 Risk factors for surgical site occurrence and hernia recurrence (Table 4) are similar to those identified in our previous studies. 46, 47 Limitations include a retrospective study design and lack of randomization, which introduce the possibility of selection bias. Another important limitation is the illness severity and complexity of the patients in our unique oncologic practice setting, which exceeds those usually encountered in abdominal wall reconstruction practices. This complexity of our patients and need for postoperative adjuvant therapy influenced our surgeons to prefer acellular dermal matrix over synthetic mesh. This differs from many other practitioners who use synthetic mesh primarily because of lesser patient complexity and initial cost pressures. Nevertheless, component separation was performed more often among obese patients with a higher body mass index. This fact may have further influenced the outcomes, particularly because component separation was found to be a protective factor against hernia recurrence. Lastly, the body mass index cutoff we identified is specific to our data set. Therefore, external validation is needed. Further studies on this topic are warranted, and the effect of preoperative weight loss and bariatric surgery in obese patients should be further investigated as a measure to reduce postoperative complications and hernia recurrence in the long term.
CONCLUSIONS
Our results show that a body mass index greater than or equal to 30 kg/m 2 is associated with significantly higher rates of wound healing complications but not with higher rates of hernia recurrence on long-term follow-up in complex abdominal wall reconstruction. Obese patients should be carefully counseled about the longer operative time and increased risk of wound healing complications. 
